300765 logo

CSPC Innovation Pharmaceutical Co., Ltd. Stock Price

SZSE:300765 Community·CN¥55.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

300765 Share Price Performance

CN¥41.18
-9.21 (-18.28%)
CN¥41.18
-9.21 (-18.28%)
Price CN¥41.18

300765 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

High growth potential and slightly overvalued.

1 Risk
2 Rewards

CSPC Innovation Pharmaceutical Co., Ltd. Key Details

CN¥2.4b

Revenue

CN¥1.4b

Cost of Revenue

CN¥905.0m

Gross Profit

CN¥1.2b

Other Expenses

-CN¥308.1m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 18, 2026
-0.22
38.51%
-13.11%
0.4%
View Full Analysis

About 300765

Founded
2006
Employees
2369
CEO
Long Dai
WebsiteView website
www.xnwpharma.net

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. It also provides technology transfer and technical consulting services of biotechnology. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.

Recent 300765 News & Updates

Recent updates

No updates